Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase 1 1

Status

Active not recruiting 3Terminated 1Completed 1

Sponsor Class

INDUSTRY 5

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 4Tumor-Agnostic 1

Conditions

Carcinoma, Non-Small-Cell Lung 35Lung Neoplasms 9Neoplasms 6Neoplasm Metastasis 5Carcinoma 5Pancreatic Neoplasms 2Ovarian Neoplasms 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thoracic Neoplasms 1Stage IB-IIIA Non-small Cell Lung Carcinoma 1Skin Neoplasms 1Respiratory Tract Neoplasms 1Respiratory Tract Diseases 1Prostatic Neoplasms 1Noonan Syndrome 1Non Small Cell Lung Cancer Metastatic 1Neoplasms, Squamous Cell 1Neoplasms by Site 1NSCLC 1Multiple Myeloma 1Lymphoma 1Lung Diseases 1Locally Advanced or Metastatic EGFR T790M+ NSCLC 1Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer 1Hematologic Neoplasms 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Carcinoma, Squamous Cell 1

Interventions

Carboplatin 23Cisplatin 19pembrolizumab 14Paclitaxel 12Gemcitabine 12Pemetrexed 11130-nm albumin-bound paclitaxel 9Everolimus 8Cetuximab 8Fluorouracil 7Axitinib 6osimertinib 5durvalumab 5Sunitinib 5Radiotherapy 5Erlotinib Hydrochloride 5Docetaxel 5Cyclophosphamide 5Albumin-Bound Paclitaxel 5Sorafenib 4Radiation 4Nivolumab 4Ipilimumab 4vosaroxin 3Radiotherapy, Intensity-Modulated 3Octreotide 3Irinotecan 3Bevacizumab 31-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 3pralsetinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Has results × Carcinoma × osimertinib × Clear all
NCT03778229 2026-04-23

SAVANNAH

AstraZeneca

Phase 2 Active not recruiting
367 enrolled 32 charts
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT04606771 2026-02-27

CoC

AstraZeneca

Phase 2 Active not recruiting
30 enrolled 20 charts
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT04035486 2025-10-10

FLAURA2

AstraZeneca

Phase 3 Active not recruiting
587 enrolled 44 charts 1 FDA
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT04816214 2024-03-05

GEOMETRY-E

Novartis

Phase 3 Terminated
6 enrolled 20 charts
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT02529995 2020-02-11

AURAChinaPK

AstraZeneca

Phase 1 Completed
31 enrolled 22 charts
Tumor-Agnostic

Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡